Yourgene Health Plc
VILGF
Other OTC0.00
USD
- -
- -
Yourgene Health Plc
VILGF
(Other OTC)
Recent
price
0.00
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- Yourgene Health Plc (ticker: VILGF) develops and commercializes genetic testing solutions focused on reproductive health, oncology, and infectious diseases. The company offers core products and services including the DPYD genotyping test for personalized cancer treatment; IONA Nx NIPT, a non-invasive prenatal screening test for chromosomal abnormalities; CE-marked PG-Seq Rapid for preimplantation genetic testing; and a range of molecular diagnostics platforms, assays, and bioinformatics software for clinical and research applications. These solutions cater to healthcare providers, laboratories, and patients seeking accurate, rapid genetic analysis, with operations spanning the United Kingdom, Europe, and select international markets. Founded in 2006 and headquartered in Manchester, United Kingdom, Yourgene Health operates as part of the Prenetics Global Limited group following its acquisition in 2023, which expanded its global reach in precision medicine. In recent developments within the last two years, the company launched enhancements to its IONA test portfolio and formed strategic distribution partnerships in Asia-Pacific regions to broaden market access for its reproductive health offerings.
Yourgene Health Launches Insight DPYD Assay
Yourgene Health Launches LightBench Discover
Yourgene Health and Genetix Launch First Local Non-invasive Prenatal Testing Service in Colombia
Yourgene Health and Laboriad Launch Non-invasive Prenatal Testing in Morocco